A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
PHASE3CompletedINTERVENTIONAL
Enrollment
375
Participants
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Ritonavir
DRUG
Nelfinavir mesylate
DRUG
Saquinavir
DRUG
Delavirdine mesylate
Trial Locations (2)
90048
Dr Charles Farthing, Los Angeles
02445
Community Research Initiative, Brookline
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT00002178 - A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients | Biotech Hunter | Biotech Hunter